切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2017, Vol. 06 ›› Issue (04) : 198 -202. doi: 10.3877/cma.j.issn.2095-3259.2017.04.002

所属专题: 专题评论 文献

专家论坛

妊娠期肝衰竭母儿预后的评估
尹玉竹1,(), 张培珍1   
  1. 1. 510630 广州,中山大学附属第三医院产科
  • 收稿日期:2017-07-14 出版日期:2017-11-18
  • 通信作者: 尹玉竹

Prognostic assessment of mother and infant in live failure during pregnancy

Yuzhu Yin1(), Peizhen Zhang1   

  • Received:2017-07-14 Published:2017-11-18
  • Corresponding author: Yuzhu Yin
引用本文:

尹玉竹, 张培珍. 妊娠期肝衰竭母儿预后的评估[J]. 中华产科急救电子杂志, 2017, 06(04): 198-202.

Yuzhu Yin, Peizhen Zhang. Prognostic assessment of mother and infant in live failure during pregnancy[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2017, 06(04): 198-202.

妊娠期肝衰竭病情凶险,孕妇和胎儿死亡率高。乙型肝炎病毒感染和妊娠期急性脂肪肝是导致我国妊娠期肝衰竭的主要原因,有效的病情评估和及时终止妊娠是改善母儿预后的主要手段。终末期肝病模型评分、肝功能CTP评分和Swansea标准对急慢性肝衰竭和妊娠期急性脂肪肝预后有一定的评估价值,但尚需在临床工作中进一步探讨。

Live failure during pregnancy often evolves critically and carries out high maternal-fetus mortality. Infection of hepatitis B virus and acute fatty liver of pregnancy (AFLP) are the most common causes of liver failure during pregnancy in China. Prognosis can be improved with effective evaluation of illness state and timely termination of pregnancy. The model for end-stage liver disease (MELD) scoring system, Child-Turcotte-Pugh (CTP) scoring system of liver function and Swansea criteria can be used to predicting the prognosis of acute-chronic hepatitis B liver failure and AFLP, but it should be further explored in clinical work.

表1 CTP评分系统[20]
[1]
中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2012年版)[J]. 中华临床感染病杂志,2012, 5(6):321-327.
[2]
曹健英,陈宝花,蒋佩茹. 妊娠合并肝衰竭患者的病死危险因素分析[J]. 现代妇产科进展,2013, 22(9):730-733.
[3]
Li XM, Deng LZ, Shen HM, et al. Liver synthetic function in predicting the prognosis of pregnancy complicating fulminant hepatitis[J]. Chin Med J (Engl), 2007, 120(24):2311-2313.
[4]
Knox TA, Olans LB. Liver disease in pregnancy[J]. N Engl J Med, 1996, 335(8):569-576.
[5]
Joshi D, James A, Quaglia A, et al. Liver disease in pregnancy[J]. The Lancet, 2010, 375(9714):594-605.
[6]
Than NN, Neuberger J. Liver abnormalities in pregnancy[J]. Best Pract Res Clin Gastroenterol, 2013, 27(4):565-575.
[7]
Jena P, Sheela CN, Venkatachala RP, et al. Obstetric outcome in women with chronic liver disease[J]. J Obstet Gynaecol India, 2017, 67(4):263-269.
[8]
Shaheen AA, Myers RP. The outcomes of pregnancy in patients with cirrhosis: a population-based study[J]. Liver Int, 2010, 30(2):275-283.
[9]
Ko H, Yoshida EM. Acute fatty liver of pregnancy[J]. Can J Gastroenterol, 2006, 20(1):25-30.
[10]
13th Asia-Pacific Congress of Clinical Microbiology and Infection Consensus Guidelines for diagnosis and treatment of liver failure[J]. Hepatobiliary Pancreat Dis Int, 2013, 12(4):346-354.
[11]
Ding G, Li Z, Zhang L, et al. Circulating full-length cytokeratin 18 for predicting prognosis of hepatitis B virus-related acute-on-chronic liver failure patients with lamivudine treatment[J]. Hepatol Res, 2016, 46(4):329-334.
[12]
Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33(2):464-470.
[13]
Kamath PS, Kim WR. The model for end-stage liver disease (MELD)[J]. Hepatology, 2007, 45(3):797-805.
[14]
Zheng MH, Shi KQ, Fan YC, et al. A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure[J]. Clin Gastroenterol Hepatol, 2011, 9(4):351-356.
[15]
于琳,曾荔苹,光晓燕. 妊娠合并重型肝炎患者MELD评分分析与终止妊娠时机[J]. 现代中西医结合杂志,2010, 19(5):524-525, 528.
[16]
杨越波,邓柳枝,李小毛. MELD评分对晚期妊娠合并重型肝炎预后的评价作用[C]. 南京:第二届围产医学新进展高峰论坛,2010.
[17]
Sun QF, Ding JG, Xu DZ, et al. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model[J]. J Viral Hepat, 2009, 16(7):464-470.
[18]
Xu X, Liu X, Ling Q, et al. Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failure[J]. PLoS One, 2013, 8(3):e58738.
[19]
Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis[J]. Gut, 2006, 55 Suppl 6:i1-i12.
[20]
Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices[J]. Br J Surg, 1973, 60:646-649.
[21]
谢仕斌,吴元凯,朱建芸,等. 慢加急性肝衰竭预后评分系统的建立与评估[J]. 中山大学学报(医学科学版), 2011, 32(6):834-840.
[22]
Knight M, Nelson-Piercy C, Kurinczuk JJ, et al. A prospective national study of acute fatty liver of pregnancy in the UK[J]. Gut, 2008, 57(7):951-956.
[23]
Goel A, Ramakrishna B, Zachariah U, et al. How accurate are the Swansea criteria to diagnose acute fatty liver of pregnancy in predicting hepatic microvesicular steatosis?[J]. Gut, 2011, 60(1):138-139, 139-140.
[24]
Meng J, Wang S, Gu Y, et al. Prenatal predictors in postpartum recovery for acute fatty liver of pregnancy: experiences at a tertiary referral center[J]. Arch Gynecol Obstet, 2016, 293(6):1185-1191.
[25]
Holt EW, Guy J, Gordon SM, et al. Acute liver failure caused by herpes simplex virus in a pregnant patient: is there a potential role for therapeutic plasma exchange?[J]. J Clin Apher, 2013, 28(6):426-429.
[26]
Qu YY, Zeng H, Guo XY, et al. Retrospective analysis of anesthetic and perioperative management in patients of acute fatty liver of pregnancy[J]. Zhonghua Yi Xue Za Zhi, 2017, 97(24):1878-1882.
[27]
Yu CB, Chen JJ, Du WB, et al. Effects of plasma exchange combined with continuous renal replacement therapy on acute fatty liver of pregnancy[J]. Hepatobiliary Pancreat Dis Int, 2014, 13(2):179-183.
[28]
Papafragkakis H, Singhal S, Anand S. Acute fatty liver of pregnancy[J]. South Med J, 2013, 106(10):588-593.
[29]
Zhou G, Zhang X, Ge S. Retrospective analysis of acute fatty liver of pregnancy: twenty-eight cases and discussion of anesthesia[J]. Gynecol Obstet Invest, 2013, 76(2):83-89.
[1] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[2] 张思平, 刘伟, 马鹏程. 全膝关节置换术后下肢轻度内翻对线对疗效的影响[J]. 中华关节外科杂志(电子版), 2023, 17(06): 808-817.
[3] 李越洲, 张孔玺, 李小红, 商中华. 基于生物信息学分析胃癌中PUM的预后意义[J]. 中华普通外科学文献(电子版), 2023, 17(06): 426-432.
[4] 张俊, 罗再, 段茗玉, 裘正军, 黄陈. 胃癌预后预测模型的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 456-461.
[5] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[6] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[7] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[8] 江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[9] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[10] 鲁鑫, 许佳怡, 刘洋, 杨琴, 鞠雯雯, 徐缨龙. 早期LC术与PTCD续贯LC术治疗急性胆囊炎对患者肝功能及预后的影响比较[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 648-650.
[11] 姜明, 罗锐, 龙成超. 闭孔疝的诊断与治疗:10年73例患者诊疗经验总结[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 706-710.
[12] 卢艳军, 马健, 白鹏宇, 郭凌宏, 刘海义, 江波, 白文启, 张毅勋. 纳米碳在腹腔镜直肠癌根治术中253组淋巴结清扫的临床效果[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 473-477.
[13] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[14] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
阅读次数
全文


摘要